piwik-script

Intern
    Institut für Hygiene und Mikrobiologie

    Drug development

    Current chemotherapeutic options for the treatment of alveolar echinococcosis are very limited. Routinely, benzimidazoles are used which target the parasite’s beta-tubulins (85% identical to mammalian beta-tubulin; Brehm et al., 1999) and which can have severe side-effects. Furthermore, benzimidazoles are parasitostatic only and often have to be given life-long (Brehm, 2013).
    Due to the available molecular information and their crucial role in parasite development, the Echinococcus signalling cascades (see host-parasite interaction) are also suitable targets for anti-parasitic chemotherapy. The level of conservation of these factors is usually lower than that of beta-tubulins. Furthermore, due to cancer research many inhibitors and modifiers of the activity of these factors are available. In this project, we are testing commercially available anti-cancer drugs (e.g. kinase inhibitors) for antiparasitic activity (in vitro cultivation system) and for direct activity towards parasite targets (e.g. p38 MAP kinases or Abl-like kinases). Once such inhibitors are identified, they will be chemically modified to generate parasite-specific drugs.

    References:

    Brehm, K., 2013 Protein kinases as drug targets in the treatment of alveolar echinococcosis.
    In Protein phosphorylation in eukaryotic parasites: novel targets for antiparasitic intervention. Drug discovery in infectious diseases (vol. 5). Edited by Doerig, C., Wiese, M., Spaeth, G. Wiley-VCH 2013; in press.

    Hemer, S., Brehm, K., 2012 In vitro efficacy of the anti-cancer drug Imatinib on Echinococcus multilocularis larvae.
    Int. J. Antimicrob. Agents 40: 458-462.

    Gelmedin, V., Spiliotis, M. & Brehm, K., 2010 Molecular Characterization of MEK1/2- and MKK3/6-like mitogen-activated protein kinase kinases (MAPKK) from the fox-tapeworm Echinococcus multilocularis.
    Int. J.Parasitol. 40: 555-567.

    Gelmedin, V., Caballero-Gamiz, R. & Brehm, K., 2008. Characterization and inhibition of a p38-like mitogen activated protein kinase (MAPK) from Echinococcus multilocularis: antiparasitic activities of p38 MAPK inhibitors.
    Biochem. Pharmacol. 76: 1068-1081.

    Spiliotis, M., Konrad, C., Gelmedin, V., Tappe, D., Brückner, S., Mösch, H.U. & Brehm, K., 2006 Characterisation of EmMPK1, an ERK-like MAP kinase from Echinococcus multilocularis which is activated in response to human epidermal growth factor.
    Int. J. Parasitol., 36: 1079-1112.

    Brehm, K., Kronthaler, K., Jura, H. & Frosch, M., 2000 Cloning and characterization of ß-tubulin genes from Echinococcus multilocularis. Mol. Biochem. Parasitol. 107: 297-302

    Hinweis zum Datenschutz

    Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Facebook weitergeleitet. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung.

    Hinweis zum Datenschutz

    Mit 'OK' verlassen Sie die Seiten der Universität Würzburg und werden zu Twitter weitergeleitet. Informationen zu den dort erfassten Daten und deren Verarbeitung finden Sie in deren Datenschutzerklärung.

    Kontakt

    Institut für Hygiene und Mikrobiologie
    Josef-Schneider-Straße 2
    97080 Würzburg

    Suche Ansprechpartner

    Campus Medizin
    Campus Medizin